Author:
Song Zhiqiang,Xu Lili,Tang Gusheng,Gao Lei,Wang Libing,Ni Xiong,Chen Li,Chen Jie,Wang Tao,Feng Dongge,Yu Xuejun,Yang Jianmin,Wang Yang
Subject
Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine
Reference29 articles.
1. Cancer Statistics, 2021;Siegel;CA Cancer J Clin,2021
2. Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China;Shi;Chin J Cancer Res,2019
3. Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma;El-Galaly;Am J Hematol,2015
4. Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Vitolo;Ann Oncol,2016
5. Non-Hodgkin lymphoma;Armitage;Lancet,2017
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献